Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK NØRRE FARIMAGSGADE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.1% 0.8% 0.9% 1.0% 0.6% 1.1% 8.1% 8.1%   Credit score (0-100)   86 91 90 85 96 83 30 30   Credit rating   A A A A AA A BB BB   Credit limit (kDKK)   415.0 926.0 961.3 669.9 1,346.9 563.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -205 -71.6 1.5 -114 -15.7 -124 0.0 0.0   EBITDA   -205 -71.6 1.5 -114 -15.7 -124 0.0 0.0   EBIT   -205 -71.6 1.5 -114 -15.7 -124 0.0 0.0   Pre-tax profit (PTP)   1,247.3 1,503.9 994.1 1,439.9 540.2 815.6 0.0 0.0   Net earnings   947.7 1,167.5 762.6 1,123.1 889.4 627.9 0.0 0.0   Pre-tax profit without non-rec. items   1,247 1,504 994 1,440 540 816 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   10,836 11,803 12,511 13,428 14,121 12,928 11,803 11,803   Interest-bearing liabilities   0.0 2,612 201 201 32.0 18.8 0.0 0.0   Balance sheet total (assets)   11,139 14,618 12,775 13,901 14,163 13,161 11,803 11,803   Net Debt   -8,513 -7,015 -7,022 -7,863 -7,319 -7,071 -11,803 -11,803     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -205 -71.6 1.5 -114 -15.7 -124 0.0 0.0   Gross profit growth   -14.8% 65.0% 0.0% 0.0% 86.2% -689.4% 0.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,139 14,618 12,775 13,901 14,163 13,161 11,803 11,803   Balance sheet change%   3.3% 31.2% -12.6% 8.8% 1.9% -7.1% -10.3% 0.0%   Added value   -204.8 -71.6 1.5 -113.7 -15.7 -123.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.1% 11.9% 7.4% 10.9% 5.3% 6.0% 0.0% 0.0%   ROI %   14.4% 12.1% 7.4% 11.0% 5.4% 6.0% 0.0% 0.0%   ROE %   8.8% 10.3% 6.3% 8.7% 6.5% 4.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   97.3% 80.7% 97.9% 96.6% 99.7% 98.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   4,157.4% 9,796.3% -467,523.3% 6,912.7% 46,769.1% 5,723.4% 0.0% 0.0%   Gearing %   0.0% 22.1% 1.6% 1.5% 0.2% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 2.3% 1.0% 6.0% 176.4% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   28.4 3.4 49.1 27.3 276.4 44.0 0.0 0.0   Current Ratio   28.4 3.4 49.1 27.3 276.4 44.0 0.0 0.0   Cash and cash equivalent   8,513.3 9,627.2 7,223.4 8,063.9 7,351.4 7,089.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,080.6 -2,700.7 3,223.6 3,172.5 4,223.5 3,139.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -72 2 -114 -16 -124 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -72 2 -114 -16 -124 0 0   EBIT / employee   0 -72 2 -114 -16 -124 0 0   Net earnings / employee   0 1,168 763 1,123 889 628 0 0